Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer.

Critical Reviews in Oncology/hematology
Supriya Gupta MohileWalter M Stadler

Abstract

To determine the baseline prevalence of cognitive impairment in older men treated with ADT and to assess changes in cognitive performance over time. Thirty-two patients (median age of 71 years, range 51-87) were administrated an extensive neuropsychological testing battery prior to ADT initiation, with 21 (65%) completing post-treatment evaluations 6 months later. At baseline, 45% scored >1.5 standard deviations below the mean on > or = 2 neuropsychological measures. Using standardized inferential statistics, no change in cognition was documented following treatment. The Reliable Change Index revealed that, on a case-by-case basis, 38% demonstrated a decline in measures of executive functioning and 48% showed improvement on measures of visuospatial abilities. Within exploratory analyses, patients who scored below expectation at baseline displayed no change in cognition, while patients with average or better scores at baseline displayed improvements in visuospatial planning and timed tests of phonemic fluency. We found a high prevalence of lower than expected cognitive performance among a sample of patients just starting ADT for prostate cancer. Assessment of baseline cognitive function should be taken into account for future re...Continue Reading

References

Feb 1, 1982·Journal of Consulting and Clinical Psychology·D GallagherL W Thompson
Sep 24, 1999·Drugs & Aging·S Basaria, A S Dobs
Mar 22, 2000·The Clinical Neuropsychologist·A M ShapiroJ Brandt
Dec 26, 2001·Archives of Neurology·R C PetersenB Winblad
Jun 20, 2002·Clinical Endocrinology·Shehzad BasariaAdrian S Dobs
Oct 1, 1955·Journal of Consulting Psychology·R M REITAN
Aug 25, 2004·Journal of Internal Medicine·R C Petersen
Dec 14, 2004·The Clinical Neuropsychologist·Simon LemayPierre-Luc Gilbert Tremblay
Sep 29, 2005·Neuropsychology·Pauline E J SpaanCees Jonker
Oct 12, 2005·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Robert J Frerichs, Holly A Tuokko
Jun 6, 2006·The Lancet Oncology·Edward M MessingUNKNOWN Eastern Cooperative Oncology Group study EST 3886
Jul 22, 2006·American Journal of Therapeutics·Anne E KaylChristina A Meyers
Jan 18, 2007·Seminars in Neurology·Ronald C Petersen
Oct 26, 2007·American Journal of Alzheimer's Disease and Other Dementias·Antoinette E ZehnderAndreas U Monsch
Mar 19, 2008·Annals of Internal Medicine·Brenda L PlassmanRobert B Wallace
May 7, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Howard ChertkowHoward Bergman
Jul 31, 2008·Cancer·Christian J NelsonAndrew J Roth

❮ Previous
Next ❯

Citations

Nov 10, 2011·Current Psychiatry Reports·Samantha B Artherholt, Jesse R Fann
Feb 22, 2012·Asian Journal of Andrology·Rhoda J JamadarPauline M Maki
Mar 3, 2012·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Kevin Duff
May 27, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Heather L McGintyPaul B Jacobsen
Nov 5, 2013·Seminars in Oncology Nursing·Catherine M Bender, Bethany D Thelen
Feb 18, 2017·Endocrine-related Cancer·Niamh L MundellSteve F Fraser
Mar 7, 2017·Urology·Bulent GunlusoyAslı Koskderelioglu
Feb 9, 2017·European Journal of Cancer Care·C J TreanorM Donnelly
Dec 18, 2013·Psycho-oncology·Jeffrey S WefelEllen R Gritz
Jun 23, 2020·American Journal of Clinical Oncology·Steven Lehrer, Peter H Rheinstein
Feb 13, 2020·Current Oncology Reports·Jonathan KlugerHerta H Chao
Oct 21, 2016·Journal of the American Geriatrics Society·Carlo AbbateSilvio Monfardini
Jun 17, 2020·Psycho-oncology·Sarah Katharina Charlotte HoltfrerichEsther Kristina Diekhof
Dec 8, 2016·Current Opinion in Supportive and Palliative Care·Lisa M Wu, Ali Amidi
Jun 16, 2021·International Journal of Urology : Official Journal of the Japanese Urological Association·Cornelie D AndelaA Edo Meinders

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.